Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View
John Mascarenhas, EHA 2023: Overview and limitations of current therapeutic options for myelofibrosis
View
Renoir phase 3 study – rituximab and lenalidomide versus rituximab for elderly patients with r/r follicular lymphoma: Umberto Vitolo, ASH 2023
View
Anna Sureda, EBMT23: Improvements in outcomes in autologous stem cell transplantation for patients with Hodgkin lymphoma
View
Anna Sureda: Highlights from EBMT23!
View
Jorge Cortes, EHA 2023: The use of quizarpenib in patients with acute myeloid leukaemia
View
The evolving treatment landscape in relapsed/refractory multiple myeloma
View
Phase III APPLY-PNH and APPOINT-PNH trials investigate iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria, 48-week data: Phillip Scheinberg, ASH 2023
View
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
View
New horizons in R/R follicular lymphoma: Focus on risk stratification and managing the practicalities of CAR T-cell therapy
View